In contrast, ALK.CAR‐Ts and GD2.CAR‐Ts were less potent against neuroblastoma tumours with lower ALK or GD2 expression, confirming the importance of antigen density for CAR‐T‐cell efficacy. The gene discussed is ALK; the disease is neuroblastoma.